Empress Therapeutics, which exited stealth mode a year ago, has already discovered 15 drug leads across multiple diseases and target classes. Launched in 2020, the Flagship Pioneering startup is now driving towards filing multiple IND applications within the next 24 months. While AI has played a role in compressing those timelines, the company is focusing…
Why AI alone won’t resolve drug discovery challenges
Big Pharma and researchers are sharpening their focus on AI to speed drug discovery. But the path to fully AI-driven drug discovery faces substantial hurdles, according to Adityo Prakash, CEO of Verseon. “When it comes to drug discovery, AI has a data problem with which the pharmaceutical industry has not yet come to terms,” he…